Ed S. Krol - Search Results

Year	Number of Results
2007	2
2008	1
2009	2
2011	1
2012	1
2013	1
2014	1
2015	3
2016	1
2017	2
2018	1
2019	3
2021	1
2022	2
2023	3
2024	0

1

The Chemistry of Creating Chemically Programmed Antibodies (cPAbs): Site-Specific Bioconjugation of Small Molecules.

Aigbogun OP, Phenix CP, Krol ES, Price EW. Aigbogun OP, et al. Among authors: krol es. Mol Pharm. 2023 Feb 6;20(2):853-874. doi: 10.1021/acs.molpharmaceut.2c00821. Epub 2023 Jan 25. Mol Pharm. 2023. PMID: 36696533 Review.

2

In vitro hepatic metabolism of the natural product quebecol.

Bernardes G, Krol ES. Bernardes G, et al. Among authors: krol es. Xenobiotica. 2023 Jan;53(1):1-11. doi: 10.1080/00498254.2023.2180691. Epub 2023 Apr 18. Xenobiotica. 2023. PMID: 36976846

3

The effect of diphenylethane side-chain substituents on dibenzocyclohexadiene formation and their inhibition of α-synuclein aggregation in vitro.

Bernardes G, Munir O, Krol ES. Bernardes G, et al. Among authors: krol es. Bioorg Med Chem. 2023 Jan 15;78:117147. doi: 10.1016/j.bmc.2022.117147. Epub 2022 Dec 26. Bioorg Med Chem. 2023. PMID: 36587551

4

An HPLC-UV validated bioanalytical method for measurement of in vitro phase 1 kinetics of α-synuclein binding bifunctional compounds.

Aigbogun OP, Nwabufo CK, Owens MN, Allen KJH, Lee JS, Phenix CP, Krol ES. Aigbogun OP, et al. Among authors: krol es. Xenobiotica. 2022 Aug;52(8):916-927. doi: 10.1080/00498254.2022.2140315. Xenobiotica. 2022. PMID: 36282181

5

Comparative pharmacokinetics of purified flaxseed and associated mammalian lignans in male Wistar rats.

Mukker JK, Singh RS, Muir AD, Krol ES, Alcorn J. Mukker JK, et al. Among authors: krol es. Br J Nutr. 2015 Mar 14;113(5):749-57. doi: 10.1017/S0007114514004371. Epub 2015 Feb 26. Br J Nutr. 2015. PMID: 25716060

6

A previously unrecognized kanosamine biosynthesis pathway in Bacillus subtilis.

Vetter ND, Langill DM, Anjum S, Boisvert-Martel J, Jagdhane RC, Omene E, Zheng H, van Straaten KE, Asiamah I, Krol ES, Sanders DA, Palmer DR. Vetter ND, et al. Among authors: krol es. J Am Chem Soc. 2013 Apr 24;135(16):5970-3. doi: 10.1021/ja4010255. Epub 2013 Apr 15. J Am Chem Soc. 2013. PMID: 23586652

7

Association Between Prerequisites and Academic Success at a Canadian University's Pharmacy Program.

Krol ES, Dobson RT, Adesina K. Krol ES, et al. Am J Pharm Educ. 2019 Feb;83(1):6491. doi: 10.5688/ajpe6491. Am J Pharm Educ. 2019. PMID: 30894763 Free PMC article.

8

Development of a UV-Stabilized Topical Formulation of Nifedipine for the Treatment of Raynaud Phenomenon and Chilblains.

Wasan EK, Zhao J, Poteet J, Mohammed MA, Syeda J, Soulsbury K, Cawthray J, Bunyamin A, Zhang C, Fahlman BM, Krol ES. Wasan EK, et al. Among authors: krol es. Pharmaceutics. 2019 Nov 9;11(11):594. doi: 10.3390/pharmaceutics11110594. Pharmaceutics. 2019. PMID: 31717566 Free PMC article.

9

Tandem mass spectrometric analysis of novel caffeine scaffold-based bifunctional compounds for Parkinson's disease.

Nwabufo CK, El-Aneed A, Krol ES. Nwabufo CK, et al. Among authors: krol es. Rapid Commun Mass Spectrom. 2019 Dec 15;33(23):1792-1803. doi: 10.1002/rcm.8540. Rapid Commun Mass Spectrom. 2019. PMID: 31351020

10

Employing in vitro metabolism to guide design of F-labelled PET probes of novel α-synuclein binding bifunctional compounds.

Nwabufo CK, Aigbogun OP, Allen KJH, Owens MN, Lee JS, Phenix CP, Krol ES. Nwabufo CK, et al. Among authors: krol es. Xenobiotica. 2021 Aug;51(8):885-900. doi: 10.1080/00498254.2021.1943566. Epub 2021 Jun 30. Xenobiotica. 2021. PMID: 34187286

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

24 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year